The gatekeeper images in hypertrophic cardiomyopathy: the role of native T1 mapping in Anderson-Fabry disease
Abstract
We presented a case of a 49-year-old presenting with atypical chest pain and hypertrophic phenotype cardiomyopathy without coronary artery disease. At cardiac magnetic resonance (CMR), the left ventricle was of normal volumes and preserved global ejection fraction with asymmetric wall hypertrophy. The evaluation of native myocardial T1 has been calculated at an average global value of 924 ms, compatible with hypertrophic phenotype cardiomyopathy with reduced native T1 values as observed in Anderson-Fabry disease. The genetic analysis confirmed the Anderson-Fabry disease with a mutation in the exon 5 of the GLA gene, revealing the mutation c.644 A>G. This case report demonstrated that the images obtained in CMR and the analysis of the T1 native mapping, compared with the normal values obtained in the Center, may be considered a gatekeeper in the diagnostic assessment, avoiding redundant examinations, and reducing costs, and radiological exposure.
References
- Desnick RJ, Ioannou YA, Eng CM. α-galactosidase a deficiency: fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th ed. McGraw Hill: New York, NY, USA, 2001; pp. 3733-74.
- Clarke JT. Narrative review: Fabry disease. Ann Intern Med 2007;146:425-33. DOI: https://doi.org/10.7326/0003-4819-146-6-200703200-00007
- Pisani A, Visciano B, Imbriaco M, et al. The kidney in Fabry’s disease. Clin Genet 2014;86:301-9. DOI: https://doi.org/10.1111/cge.12386
- Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comphrensive review. J Cardiovasc Megn Reson 2016;18:89. DOI: https://doi.org/10.1186/s12968-016-0308-4
- Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 2013;6:392-8. DOI: https://doi.org/10.1161/CIRCIMAGING.112.000070
- Esposito R, Santoro C, Mandoli GE, et al. Cardiac imaging in Anderson-Fabry disease: past, present and future. J Clin Med 2012;10:1994. DOI: https://doi.org/10.3390/jcm10091994
- Deva DP, Hanneman K, Li Q, et al. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-fabry disease. J Cardiovasc Magn Reson 2016;18:14. DOI: https://doi.org/10.1186/s12968-016-0233-6
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2024 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.